| 注册
首页|期刊导航|中国临床药理学杂志|创新性药物临床试验的风险管理

创新性药物临床试验的风险管理

范华莹 谢振伟 王瓅珏 张华 王豪

中国临床药理学杂志2017,Vol.33Issue(23):2471-2473,3.
中国临床药理学杂志2017,Vol.33Issue(23):2471-2473,3.DOI:10.13699/j.cnki.1001-6821.2017.23.044

创新性药物临床试验的风险管理

Risk management of the innovative drug clinical trials

范华莹 1谢振伟 1王瓅珏 1张华 1王豪1

作者信息

  • 1. 北京大学人民医院科研处药物临床试验机构,北京100044
  • 折叠

摘要

Abstract

In recent years,with the improvement of drug innovation capacity in China,the number of investigational new drug application and new drug application increased.For the innovative drugs,because their pharmacodynamics,pharmacokinetics,efficacy and safety are unknown,we need to gradually explore them through clinical trials,during which the risk is extremely high.This article will analyze the risk factors in the innovative drug clinical trials and put forward strategies to improve the rate of success.

关键词

创新性药物/临床试验/风险管理

Key words

innovative drug/clinical trial/risk management

分类

医药卫生

引用本文复制引用

范华莹,谢振伟,王瓅珏,张华,王豪..创新性药物临床试验的风险管理[J].中国临床药理学杂志,2017,33(23):2471-2473,3.

基金项目

北京国际医药临床研发平台(CRO平台)基金资助项目 (CRO平台)

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量2
|
下载量0
段落导航相关论文